Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rodolico

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Schizophrenia (Heidelberg, Germany)|December 17, 2025
Empowering clinicians and patients in antipsychotic dose reduction for schizophrenia: the role of online toolsStefan Leucht, Alessandro Rodolico
Journal of Integrative Neuroscience|September 30, 2024
The Fascinating Link between Psychedelics and NeuroplasticityCarmen Concerto, Giuseppe Lanza, Alessandro Rodolico
The Lancet. Psychiatry|March 20, 2022
Relapse prevention in schizophrenia - Authors' replyIrene Bighelli, Alessandro Rodolico, Stefan Leucht
Translational Medicine @ Unisa|December 25, 2023
What Evidence-based Medicine (EBM) Doesn't Say About Allergen-specific Immunotherapy (AIT)Gabriele Di Lorenzo, Marcello Melluso, Alessandro Rodolico
The Lancet. Psychiatry|March 20, 2022
Confidence of evidence should be considered in ranking of treatments in the network meta-analysis - Authors' replyIrene Bighelli, Alessandro Rodolico, Spyridon Siafis, et al.
Translational Medicine @ Unisa|February 12, 2024
Allergic Diseases in the ElderlyGabriele Di Lorenzo, Marcello Melluso, Alessandro Rodolico, et al.
International Clinical Psychopharmacology|December 1, 2017
Asenapine in the management of impulsivity and aggressiveness in bipolar disorder and comorbid borderline personality disorder: an open-label uncontrolled studyAndrea Aguglia, Ludovico Mineo, Alessandro Rodolico, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 18, 2026
Comparative Efficacy of Subcutaneous and Sublingual Allergen Immunotherapy for Grass Pollen-Induced Allergic Rhinoconjunctivitis: Pairwise and Adjusted Indirect Treatment Comparison of Standardized ALK ProductsGabriele Di Lorenzo, Marcello Melluso, Alessandro Rodolico, et al.
Brain Sciences|June 27, 2024
Neutrophil-Lymphocyte Ratio Values in Schizophrenia: A Comparison between Oral and Long-Acting Antipsychotic TherapiesAntonino Messina, Fabrizio Bella, Giuliana Maccarone, et al.
Schizophrenia Research|April 16, 2023
How should patient decision aids for schizophrenia treatment be designed? - A scoping reviewKatharina Müller, Florian Schuster, Alessandro Rodolico, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Schizophrenia (Heidelberg, Germany)|December 17, 2025
Empowering clinicians and patients in antipsychotic dose reduction for schizophrenia: the role of online toolsStefan Leucht, Alessandro Rodolico
Journal of Integrative Neuroscience|September 30, 2024
The Fascinating Link between Psychedelics and NeuroplasticityCarmen Concerto, Giuseppe Lanza, Alessandro Rodolico
The Lancet. Psychiatry|March 20, 2022
Relapse prevention in schizophrenia - Authors' replyIrene Bighelli, Alessandro Rodolico, Stefan Leucht
Translational Medicine @ Unisa|December 25, 2023
What Evidence-based Medicine (EBM) Doesn't Say About Allergen-specific Immunotherapy (AIT)Gabriele Di Lorenzo, Marcello Melluso, Alessandro Rodolico
The Lancet. Psychiatry|March 20, 2022
Confidence of evidence should be considered in ranking of treatments in the network meta-analysis - Authors' replyIrene Bighelli, Alessandro Rodolico, Spyridon Siafis, et al.
Translational Medicine @ Unisa|February 12, 2024
Allergic Diseases in the ElderlyGabriele Di Lorenzo, Marcello Melluso, Alessandro Rodolico, et al.
International Clinical Psychopharmacology|December 1, 2017
Asenapine in the management of impulsivity and aggressiveness in bipolar disorder and comorbid borderline personality disorder: an open-label uncontrolled studyAndrea Aguglia, Ludovico Mineo, Alessandro Rodolico, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 18, 2026
Comparative Efficacy of Subcutaneous and Sublingual Allergen Immunotherapy for Grass Pollen-Induced Allergic Rhinoconjunctivitis: Pairwise and Adjusted Indirect Treatment Comparison of Standardized ALK ProductsGabriele Di Lorenzo, Marcello Melluso, Alessandro Rodolico, et al.
Brain Sciences|June 27, 2024
Neutrophil-Lymphocyte Ratio Values in Schizophrenia: A Comparison between Oral and Long-Acting Antipsychotic TherapiesAntonino Messina, Fabrizio Bella, Giuliana Maccarone, et al.
Schizophrenia Research|April 16, 2023
How should patient decision aids for schizophrenia treatment be designed? - A scoping reviewKatharina Müller, Florian Schuster, Alessandro Rodolico, et al.
Pageof 8